-
- David Devos
- Department of Medical Pharmacology, Faculté de Médecine Lille2, Lille Nord de France University, CHU Lille, Lille, France.
-
- Caroline Moreau
- Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Jean Christophe Devedjian
- EA 1046, Lille Nord de France University, Lille, France.
-
- Jérome Kluza
- Unit 837 Equipe 4 Inserm and Faculté de Médecine, Lille Nord de France University, Lille, France.
-
- Maud Petrault
- Department of Medical Pharmacology, Faculté de Médecine Lille2, Lille Nord de France University, CHU Lille, Lille, France.
-
- Charlotte Laloux
- Department of Medical Pharmacology, Faculté de Médecine Lille2, Lille Nord de France University, CHU Lille, Lille, France.
-
- Aurélie Jonneaux
- Department of Medical Pharmacology, Faculté de Médecine Lille2, Lille Nord de France University, CHU Lille, Lille, France.
-
- Gilles Ryckewaert
- Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Guillaume Garçon
- Department of Toxicology, Public Health and Environment, EA4483, Faculté des Sciences Pharmaceutiques et Biologiques de Lille, Lille, France.
-
- Nathalie Rouaix
- Department of Molecular Biology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Alain Duhamel
- Department of Biostatistics, Lille Nord de France University, CHU Lille, Lille, France.
-
- Patrice Jissendi
- Department Neuroradiology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Kathy Dujardin
- Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Florent Auger
- EA 1046, Lille Nord de France University, Lille, France.
-
- Laura Ravasi
- EA 1046, Lille Nord de France University, Lille, France.
-
- Lucie Hopes
- Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Guillaume Grolez
- Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Wance Firdaus
- Department of Medical Pharmacology, Faculté de Médecine Lille2, Lille Nord de France University, CHU Lille, Lille, France.
-
- Bernard Sablonnière
- Department of Molecular Biology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Isabelle Strubi-Vuillaume
- Department of Molecular Biology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Noel Zahr
- Department of Pharmacology, APHP, Pitié-Salpêtrière Hospital, Paris, France.
-
- Alain Destée
- Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Jean-Christophe Corvol
- INSERM, CR-ICM, UMRS975, CNRS UMR7225, UPMC, INSERM, CIC-9503, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France.
-
- Dominik Pöltl
- Doerenkamp-Zbinden Chair for In Vitro Toxicology and Biomedicine, University of Konstanz, Konstanz, Germany.
-
- Marcel Leist
- Doerenkamp-Zbinden Chair for In Vitro Toxicology and Biomedicine, University of Konstanz, Konstanz, Germany.
-
- Christian Rose
- Department of Hematology, Hôpital Saint Vincent de Paul, Lille Nord de France University, Lille, France.
-
- Luc Defebvre
- Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France.
-
- Philippe Marchetti
- Unit 837 Equipe 4 Inserm and Faculté de Médecine, Lille Nord de France University, Lille, France.
-
- Z. Ioav Cabantchik
- Della Pergola Chair, Alexander Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel.
-
- Régis Bordet
- Department of Medical Pharmacology, Faculté de Médecine Lille2, Lille Nord de France University, CHU Lille, Lille, France.
収録刊行物
-
- Antioxidants & Redox Signaling
-
Antioxidants & Redox Signaling 21 (2), 195-210, 2014-07-10
Mary Ann Liebert Inc
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360855568611336704
-
- ISSN
- 15577716
- 15230864
- http://id.crossref.org/issn/15230864
-
- データソース種別
-
- Crossref